“…From the clinical point of view, we discriminate between two large families of lymphoma: the classical Hodgkin lymphoma (CHL) and the non-Hodgkin lymphoma (NHL). Therapeutic approach and prognosis are very different between these two types of neoplasm and even between their various histological subtypes [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ]. The need of a correct and rapid diagnosis is therefore crucial for channeling patients to a proper chemotherapy, improving survival rates.…”